✦ LIBER ✦

Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes

✍ Scribed by Loretta L. Nielsen; Andrew A. Young; David G. Parkes

Book ID: 116857385
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 343 KB
Volume: 117
Category: Article
ISSN: 0167-0115
DOI: 10.1016/j.regpep.2003.10.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Exenatide (Exendin-4) on Glyc

Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

✍ Buse, J. B.; Henry, R. R.; Han, J.; Kim, D. D.; Fineman, M. S.; Baron, A. D. 📂 Article 📅 2004 🏛 American Diabetes Association 🌐 English ⚖ 228 KB

Effect on Glycemic Control of Exenatide

Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

✍ Fineman, Mark S. (author);Bicsak, Thomas A. (author);Shen, Larry Z. (author);Tay 📂 Article 📅 2003 🏛 American Diabetes Association 🌐 English ⚖ 156 KB

Effect on Glycemic Control of Exenatide

Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

✍ Fineman, Mark S. (author);Bicsak, Thomas A. (author);Shen, Larry Z. (author);Tay 📂 Article 📅 2003 🏛 American Diabetes Association 🌐 English ⚖ 156 KB

Continuous subcutaneous delivery of exen

Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes

✍ Henry, Robert R.; Rosenstock, Julio; Logan, Douglas; Alessi, Thomas; Luskey, Ken 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 375 KB

[RSC Drug Discovery] New Therapeutic Str

[RSC Drug Discovery] New Therapeutic Strategies for Type 2 Diabetes Volume 74 || Chapter 11. The Discovery and Development of MB07803, a Second-Generation Fructose-1,6-bisphosphatase Inhibitor with Improved Pharmacokinetic Properties, as a Potential Treatment of Type 2 Diabetes

✍ Jones, Rob M 📂 Article 📅 2012 🏛 Royal Society of Chemistry ⚖ 720 KB

Abstract: 997 ROMEO (RETHINK ORGANIZATIO

Abstract: 997 ROMEO (RETHINK ORGANIZATION TO IMPROVE EDUCATION AND OUTCOMES). A 4-YEAR MULTICENTRE RANDOMISED CONTROLLED TRIAL OF GROUP CARE FOR THE MANAGEMENT OF TYPE 2 DIABETES

✍ Trento, M; Porta, M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 82 KB